scPharmaceuticals to Present in Two Upcoming Investor Conferences

Rhea-AI Summary

scPharmaceuticals (Nasdaq: SCPH) announced that CEO John Tucker will participate in two investor conferences: the Cowen 41st Annual Healthcare Conference on March 4 at 10:30 AM EDT and the H.C. Wainwright Global Life Sciences Conference from March 9 to March 10. A webcast of Tucker's presentation will be available on-demand starting March 9 at 7 AM ET. The company focuses on developing products that enhance the delivery of infused therapies and aims to reduce healthcare costs.

BURLINGTON, Mass., Feb. 25, 2021 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, today announced that John Tucker, president & chief executive officer, will participate in two upcoming investor conferences.

Event:

Cowen 41^st Annual Healthcare Conference
Thursday, March 4
10:30am EDT

H.C. Wainwright Global Life Sciences Conference
Tuesday, March 9 – Wednesday, March 10
A webcast of Mr. Tucker’s presentation will be available on-demand as of 7am ET, Tuesday, March 9

A live webcast of both presentations can be accessed under “News & Events” in the Investor Relations section of the Company’s website, www.scpharmaceuticals.com.

About scPharmaceuticals
scPharmaceuticals is a pharmaceutical company focused on developing and commercializing products that are designed to reduce healthcare costs and improve health outcomes. The Company develops, internally and through strategic partnerships, innovative products and solutions that aim to expand and advance the outpatient care of select acute conditions. The Company’s lead programs focus on the subcutaneous, self-administration of IV-strength treatments in heart failure and infectious disease. scPharmaceuticals is headquartered in Burlington, MA. For more information, please visit www.scPharmaceuticals.com.

Katherine Taudvin
scPharmaceuticals Inc., 781-301-6706
ktaudvin@scpharma.com

Investors:
Hans Vitzthum
LifeSci Advisors, 617-430-7578
hans@lifesciadvisors.com

FAQ

When will scPharmaceuticals participate in the Cowen 41st Annual Healthcare Conference?

scPharmaceuticals will participate in the Cowen 41st Annual Healthcare Conference on March 4 at 10:30 AM EDT.

What conferences is scPharmaceuticals CEO John Tucker attending?

John Tucker is attending the Cowen 41st Annual Healthcare Conference on March 4 and the H.C. Wainwright Global Life Sciences Conference from March 9 to March 10.

When will the webcast of John Tucker's presentation be available?

The webcast of John Tucker's presentation will be available on-demand starting March 9 at 7 AM ET.

What is the focus of scPharmaceuticals as a company?

scPharmaceuticals focuses on developing and commercializing products that optimize the delivery of infused therapies and reduce healthcare costs.

What are the key dates for scPharmaceuticals investor conferences?

The key dates are March 4 for the Cowen Conference and March 9-10 for the H.C. Wainwright Conference.